Related Experiment Video
Updated: Dec 1, 2025
06:41
Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells
Published on: May 19, 2023
2.3K
[Important issues in long-term hematological cancer survivors]
1Pediatric Medical Center, Ehime Prefectural Central Hospital.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|November 9, 2020
Summary
Late effects in hematological cancer survivors vary by age, cancer type, and treatment. Key concerns include secondary cancers and complications after hematopoietic stem cell transplantation.
Area of Science:
- Oncology
- Hematology
- Survivorship Care
Background:
- Hematological cancer survivors face significant long-term health challenges.
- Late effects can impact quality of life and survival.
Purpose of the Study:
- To review late effects in hematological cancer survivors.
- To identify risk factors and characteristics of these late effects.
- To compare outcomes between different treatment modalities, including hematopoietic stem cell transplantation.
Main Methods:
- Literature review of existing data on hematological cancer survivors.
- Selection and analysis of representative late effects.
- Comparison of late effects based on patient and treatment characteristics.
Main Results:
- Late effects and their burden are influenced by age, primary cancer, and treatment.
- Secondary cancers are a major life-threatening concern.
- Hematopoietic stem cell transplantation is associated with specific late effects.
Conclusions:
- Understanding late effects is crucial for improving survivorship care.
- Risk stratification and tailored follow-up are essential.
- Further research on long-term outcomes and management strategies is warranted.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
665
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
665
01:21Cancer Survival Analysis
548
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
548
02:56Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
01:16Kidney Transplant III: Nursing Management
207
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
207
01:21Stem Cell Therapy for Tissue Regeneration
4.4K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.4K
01:19Multipotency of Hematopoietic Stem Cells
3.6K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.6K